Pantoprazole Teva (Pantoprazole)

Pantoprazole Teva is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions:

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
• Erosive esophagitis: accelerates mucosal healing and reduces recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.
• Prevention of NSAID‑induced gastric ulcers: lowers ulcer incidence in at‑risk patients.
• Healing of duodenal ulcers: supports ulcer resolution when used as part of standard therapy.

• Pantoprazole selectively and irreversibly inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid production, it markedly reduces both basal and stimulated gastric acidity, allowing damaged mucosa to heal and preventing further acid‑related injury.

Pantoprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity, often transient.
• Diarrhoea: loose stools that usually resolve without intervention.
• Nausea: occasional feeling of queasiness, especially after the first dose.
• Abdominal pain: cramp‑like discomfort in the stomach region.
• Flatulence: increased intestinal gas.
• Constipation: reduced bowel movements, generally mild.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): difficulty breathing, swelling of face or throat.
• Clostridioides difficile infection: persistent watery diarrhoea, abdominal cramping.
• Low magnesium levels (hypomagnesemia): muscle weakness, irregular heartbeat.
• Bone fractures (with long‑term use): increased risk of hip, wrist or spine fractures.
• Liver enzyme elevation: abnormal liver function tests indicating hepatic stress.
• Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When prescribing Pantoprazole Teva, clinicians should consider several safety aspects:

• Assess renal function: dose adjustment may be required in severe impairment.
• Review concomitant medications: potential for drug‑drug interactions, especially with antiplatelet agents.
• Monitor long‑term users: watch for osteoporosis‑related fractures and magnesium deficiency.
• Use cautiously in pregnancy: only if the potential benefit outweighs risk.
• Evaluate for hepatic disease: dose may need modification in severe liver dysfunction.
• Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Pantoprazole Teva can affect the pharmacokinetics of several co‑administered drugs. Awareness of these interactions helps maintain therapeutic efficacy.

Major Interactions (Avoid)

• Ketoconazole and itraconazole: reduced antifungal absorption; avoid concurrent use.
• Atazanavir and nelfinavir: markedly decreased antiviral levels; contraindicated.

Moderate Interactions (Monitor Closely)

• Clopidogrel: diminished antiplatelet effect; consider alternative therapy.
• Warfarin: potential increase in INR; monitor coagulation parameters.
• Methotrexate: increased serum concentrations; check renal function and adjust dose if needed.
• Digoxin: slight rise in serum levels; observe for toxicity signs.